First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: The gastric hypothesis

Surgical Endoscopy

Volumn 25, Issue 11, 2011, Pages 3540-3550

  Basso, N ^a   Capoccia, D ^a   Rizzello, M ^a   Abbatini, F ^a   Mariani, P ^a   Maglio, C ^a   Coccia, F ^a   Borgonuovo, G ^a   De Luca, M L ^a   Asprino, R ^a   Alessandri, G ^a   Casella, G ^a   Leonetti, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Glucose metabolism; Metabolic surgery; Sleeve gastrectomy; Type 2 diabetes

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE YY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; SLEEVE GASTRECTOMY; THERAPY EFFECT; UPREGULATION; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 82355169974     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-011-1755-5     Document Type: Article

References (35)

1. CD Sjöström L Lissner H Wedel L Sjöström 1999 Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study Obes Res 7 5 477 485 10509605
2. H Buchwald R Estok K Fahrbach D Banel MD Jensen WJ Pories JP Bantle I Sledge 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 3 205 206 10.1016/j.amjmed.2008.09.041
3. D Cottam FG Qureshi SG Mattar S Sharma S Holover G Bonanomi R Ramanathan P Schauer 2006 Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity Surg Endosc 20 6 859 863 16738970 10.1007/s00464-005-0134-5 1:STN:280:DC%2BD28zisVegtg%3D%3D (Pubitemid 43825185)
4. S Moon Han WW Kim JH Oh 2005 Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients Obes Surg 15 10 1469 1475 16354529 10.1381/096089205774859227 (Pubitemid 41746424)
5. M Gagner M Detail TL Kalberer AL Erickson RD Crosby 2009 The second international consensus summit for sleeve gastrectomy Surg Obes Relat Dis 5 4 476 487 19632647 10.1016/j.soard.2009.06.001
6. J Vidal A Ibarzabal F Romero S Delgado D Momblán L Flores A Lacy 2008 Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects Obes Surg 18 9 1077 1082 18521701 10.1007/s11695-008-9547-2 1:STN:280:DC%2BD1crhtVCrtw%3D%3D
7. F Abbatini M Rizzello G Casella G Alessandri D Capoccia F Leonetti N Basso 2010 Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes Surg Endosc 24 5 1005 1010 19866235 10.1007/s00464-009-0715-9 1:STN:280:DC%2BC3c3ptFyrsA%3D%3D
8. M Rizzello F Abbatini G Casella G Alessandri A Fantini F Leonetti N Basso 2010 Early postoperative insulin-resistance changes after sleeve gastrectomy Obes Surg 20 1 50 55 19916040 10.1007/s11695-009-0017-2
9. S Salinari A Bertuzzi S Asnaghi C Guidone M Manco G Mingrone 2009 First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery Diabetes Care 32 3 375 380 19033407 10.2337/dc08-1314 1:CAS:528:DC%2BD1MXjvVyqsbs%3D
10. R Peterli B Wölnerhanssen T Peters N Devaux B Kern C Christoffel-Courtin J Drewe M von Flüe C Beglinger 2009 Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial Ann Surg 250 2 234 241 19638921 10.1097/SLA.0b013e3181ae32e3
11. AH Mokdad ES Ford BA Bowman WH Dietz F Vinicor VS Bales JS Marks 2001 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 1 76 79 10.1001/jama.289.1.76
12. V Hainer H Toplak A Mitrakou 2008 Treatment modalities of obesity: what fits whom? Diabetes Care 31 Suppl 2 S269 S277 18227496 10.2337/dc08-s265
13. R Rosenthal X Li S Samuel P Martinez C Zheng 2008 Effect of sleeve gastrectomy on patients with diabetes mellitus Surg Obes Relat Dis 5 4 429 434 19342307 10.1016/j.soard.2008.11.006
14. AP Schulman F Del Genio N Sinha F Rubino 2009 "Metabolic" surgery for the treatment of type 2 diabetes Endocr Pract 15 6 624 631 19625245 10.4158/EP09170.RAR
15. E Ferrannini G Mingrone 2009 Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes Diabetes Care 32 3 514 520 19246589 10.2337/dc08-1762
16. F Rubino A Forgione DE Cummings M Vix Mingrone M Castagneto J Marescaux 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 5 741 749 17060767 10.1097/01.sla.0000224726.61448.1b (Pubitemid 44629948)
17. WJ Pories RJ Albrecht 2001 Etiology of type II diabetes mellitus: role of the foregut World J Surg 25 527 531 11344408 10.1007/s002680020348 1:STN:280:DC%2BD3M3kt1eqtA%3D%3D (Pubitemid 32455209)
18. MS Hickey WJ Pories KG MacDonald Jr. KA Cory GL Dohm MS Swanson RG Israel HA Barakat RV Considine JF Caro JA Houmard 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227 5 637 643 9605655 10.1097/00000658-199805000-00004 1:STN:280:DyaK1c3ms1KqsA%3D%3D discussion 643-644 (Pubitemid 28530913)
19. C Guidone M Manco E Valera-Mora A Iaconelli D Gniuli A Mari G Nanni M Castagneto M Calvani G Mingrone 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 7 2025 2031 16804072 10.2337/db06-0068 1:CAS:528:DC%2BD28XmvVChtL4%3D (Pubitemid 44509976)
20. L Briatore B Salani G Andraghetti C Danovaro E Sferrazzo N Scopinaro GF Adami D Maggi R Cordera 2008 Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion Obesity 16 1 77 81 18223616 10.1038/oby.2007.9 (Pubitemid 351271953)
21. F Rubino 2008 Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis Diabetes Care 31 Suppl 2 S290 S296 18227499 10.2337/dc08-s271
22. DG Bruce DJ Chisholm LH Storlien EW Kraegen 1988 Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes Diabetes 37 6 736 744 3289994 10.2337/diabetes.37.6.736 1:STN:280:DyaL1c3lsFGhug%3D%3D (Pubitemid 19043181)
23. M Laville E Disse 2009 Bariatric surgery for diabetes treatment: why should we go rapidly to surgery Diabetes Metab 35 6 Pt 2 562 563 20152744 10.1016/S1262-3636(09)73466-4 1:STN:280:DC%2BC3c7jslWquw%3D%3D
24. A Kubosaki S Nakamura AL Notkins 2005 Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice Diabetes 54 Suppl 2 S46 S51 16306340 10.2337/diabetes.54.suppl-2.S46 (Pubitemid 43343330)
25. JC Henquin M Nenquin A Szollosi A Kubosaki AL Notkins 2008 Insulin secretion in islets from mice with a double knockout for the dense core vesicle proteins islet antigen-2 (IA-2) and IA-2beta Endocrinology 196 3 573 581 10.1677/JOE-07-0496 1:CAS:528:DC%2BD1cXkt1Cgurg%3D (Pubitemid 351425513)
26. F Leonetti G Silecchia G Iacobellis MC Ribaudo A Zappaterreno C Tiberti CV Iannucci N Perrotta V Bacci MS Basso N Basso U Di Mario 2003 Different plasma gherlin levels after laparoscopic gastric by-pass and adjustable gastric banding in morbid obese subjects J Clin Endocrinol Metab 88 9 4227 4231 12970291 10.1210/jc.2003-030133 1:CAS:528:DC%2BD3sXntlagsr0%3D (Pubitemid 37153724)
27. F Leonetti G Iacobellis MC Ribaudo A Zappaterreno C Tiberti CV Iannucci E Vecci U Di Mario 2004 Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity Regul Pept 122 3 179 183 15491789 10.1016/j.regpep.2004. 06.014 1:CAS:528:DC%2BD2cXos1eiu7k%3D (Pubitemid 39371167)
28. K Dezaki H Sone T Yada 2008 Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis Pharmacol Ther 118 2 239 249 18433874 10.1016/j.pharmthera.2008.02.008 1:CAS:528: DC%2BD1cXlslOrsLw%3D
29. SN Karamanakos K Vagenas F Kalfarentzos TK Alexandrides 2008 Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study Ann Surg 247 3 401 407 18376181 10.1097/SLA.0b013e318156f012
30. ET Vestergaard CB Djurhuus J Gjedsted S Nielsen N Møller JJ Holst JO Jørgensen O Schmitz 2008 Acute effects of ghrelin administration on glucose and lipid metabolism J Clin Endocrinol Metab 93 2 438 444 18042651 10.1210/jc.2007-2018 1:CAS:528:DC%2BD1cXit1SntL8%3D (Pubitemid 351240813)
31. AM van den Hoek AC Heijboer PJ Voshol LM Havekes JA Romijn EP Corssmit H Pijl 2007 Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice Am J Physiol Endocrinol Metab 292 E238 E245 16940471 10.1152/ajpendo.00239.2006 (Pubitemid 46052946)
32. JJ Meier B Gallwitz S Salmen O Goetze JJ Holst WE Schmidt MA Nauck 2003 Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes J Clin Endocrinol Metab 88 2719 2725 12788879 10.1210/jc.2003-030049 1:CAS:528:DC%2BD3sXkslCrs7k%3D (Pubitemid 36733545)
33. TL Kindel SM Yoder RJ Seeley DA D'Alessio P Tso 2009 Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism J Gastrointest Surg 13 10 1762 1772 19488823 10.1007/s11605-009-0912-9
34. SJ Konturek J Pepera K Zabielski PC Konturek T Pawlik A Szlachcic EG Hahn 2003 Brain-gut axis in pancreatic secretion and appetite control J Physiol Pharmacol 54 3 293 317 14566070 1:CAS:528:DC%2BD3sXosFCiu7o%3D (Pubitemid 37168996)
35. D Perez-Tilve R Nogueiras F Mallo SC Benoit M Tschoep 2006 Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism Endocrine 29 1 61 16622293 10.1385/ENDO:29:1:61 1:CAS:528: DC%2BD28XksFant78%3D (Pubitemid 43780347)